Chronic Kidney Disease Stage V

1

Review clinical trials related to Chronic Kidney Disease Stage V. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Autogenic Relaxation and Murottal Therapy in Hemodialysis Patients

This quasi-experimental study aims to evaluate the effect of combined autogenic relaxation and Surah Ar-Rahman murottal therapy on anxiety, sleep quality, and hemodynamic parameters in hemodialysis patients. A pretest-posttest control group design will be used involving 76 participants undergoing routine hemodialysis. Participants will be assigned to an intervention group receiving structured autogenic relaxation followed by murottal therapy and a control group receiving standard care with music listening. Anxiety, sleep quality, and hemodynamic parameters will be measured at baseline and after a 6-week intervention period. The findings are expected to support the use of non-pharmacological and spiritual-based interventions in improving psychological and physiological outcomes in hemodialysis patients.

Participants needed: 76
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Universitas Muhammadiyah SurakartaUpdated: Feb 17, 2026Locations: 1
Eligibility criteria

Patients diagnosed with stage V chronic kidney disease. [+5]

Having a severe heart condition or an unstable critical condition. [+3]